Listed

Xeriant, Inc.: Form 10-Q for the period ended Mar 31, 2024

Filed with the SEC on May 14, 2024 and accepted by EDGAR at May 14, 2024, 13:20 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2024-01-01 to 2024-03-31$67.5kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2023-07-01 to 2024-03-31$147.3kus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2024-01-01 to 2024-03-31−$353.0kus-gaap:OperatingIncomeLoss
Operating income9 months2023-07-01 to 2024-03-31−$1.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2024-01-01 to 2024-03-31$28.6kus-gaap:InterestExpense
Interest expense9 months2023-07-01 to 2024-03-31$895.9kus-gaap:InterestExpense
Net income3 months2024-01-01 to 2024-03-31−$384.1kus-gaap:NetIncomeLoss
Net income9 months2023-07-01 to 2024-03-31−$1.9mus-gaap:NetIncomeLoss
Operating cash flow9 months2023-07-01 to 2024-03-31−$1.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2023-07-01 to 2024-03-31$0us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Current assetsAt period end2024-03-31$389.4kus-gaap:AssetsCurrent
Total assetsAt period end2024-03-31$451.8kus-gaap:Assets
Current liabilitiesAt period end2024-03-31$8.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-03-31$8.6mus-gaap:Liabilities
Shareholders' equityAt period end2024-03-31−$8.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001477932-24-002829. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.